Search results
Bitcoin declines 3% to its lowest levels since June 25
CNBC Awaaz· 5 hours agoSeveral other cryptocurrencies were also trading in the red. The second-most valued digital asset...
The Konate conundrum: Liverpool must consider sale if fitness issues don't get sorted
Anfield Watch· 5 hours agoThere was a period when Ibrahima Konate felt bordering on untouchable at Liverpool, and the natural...
Reassessing last summer's transfer window: Why Chelsea will improve, Man United will regress
ESPN· 5 hours agoThe transfer window has only now officially opened, but the biggest move of the summer happened a...
Moto G85 5G Is Set to Launch in India on This Date
Gadgets 360· 5 hours agoMoto G85 5G will launch in India next week, the company confirmed via a social media post on Wednesday. The smartphone made its debut in Europe on June...
China’s BYD set to overtake Tesla as the world's largest BEV maker, again
Firstpost· 6 hours agoChinese electric vehicle (EV) manufacturer BYD is on course to surpass Tesla in battery electric...
Top 10 world’s most liveable cities in 2024
Indian Express· 6 hours agoCurious about the most desirable cities to live in the world? Find out which cities make the cut and why they shine as the best places to call home.
US Independence Day 2024: 10 Fun Facts About America
NDTV· 6 hours agoUS Independence Day 2024: Known for its cultural diversity and lack of an official language, the US hosts people speaking over 350 languages. With a rich...
Bansal Wire IPO: Should you subscribe to it? Know all about it here | Business Insider India
Business Insider India· 6 hours ago, which manufactures stainless steel wires, opens for subscription today and will remain till July...
Two bold ideas to change the energy industry forever
Utility Dive· 6 hours agoNow may be an ideal time to make dramatic, fundamental changes to how we transport electricity, deliver it to customers and fund new projects, writes...
5 FDA decisions to watch in the third quarter
BioPharma Dive· 6 hours agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...